CAS: 1350544-93-2
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | SKLB-1028 REF: TR-S555010CAS: 1350544-93-2 | - - - | 3.568,00 € | Sex 10 Jan 25 |
 | 9-Isopropyl-N2-(4-(4-methylpiperazin-1-yl)phenyl)-N8-(pyridin-3-yl)-9H-purine-2,8-diamine REF: 3D-AEC54493CAS: 1350544-93-2 | Min. 95% | A consultar | Seg 13 Jan 25 |
 | SKLB 1028 REF: TM-T34656CAS: 1350544-93-2 | 99.71% - 99.85% | 56,00 €~1.616,00 € | Ter 21 Jan 25 |
9-Isopropyl-N2-(4-(4-methylpiperazin-1-yl)phenyl)-N8-(pyridin-3-yl)-9H-purine-2,8-diamine
CAS:1350544-93-2
Please enquire for more information about 9-Isopropyl-N2-(4-(4-methylpiperazin-1-yl)phenyl)-N8-(pyridin-3-yl)-9H-purine-2,8-diamine including the price, delivery time and more detailed …
Fórmula:
C24H29N9
Pureza:
Min. 95%
Peso molecular:
443.5 g/mol
Ref: 3D-AEC54493
| 100mg | A consultar |
Entrega estimada em Estados Unidos, Segunda-feira 13 de Janeiro de 2025
SKLB 1028
CAS:1350544-93-2
SKLB 1028, an oral EGFR/FLT3/Abl inhibitor, excels in AML and CML with Abl mutations.
Fórmula:
C24H29N9
Pureza:
99.71% - 99.85%
Cor e Forma:
Solid
Peso molecular:
443.55
Ref: TM-T34656
| 1mg | 56,00 € | ||
| 5mg | 120,00 € | ||
| 10mg | 188,00 € | ||
| 25mg | 378,00 € | ||
| 50mg | 560,00 € | ||
| 100mg | 802,00 € | ||
| 200mg | 634,00 € | ||
| 500mg | 1.616,00 € | ||
| 1mL*10mM (DMSO) | 144,00 € |
Entrega estimada em Estados Unidos, Terça-feira 21 de Janeiro de 2025
